HPN-100 + Placebo
Phase 2Completed 1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Cirrhosis
Conditions
Cirrhosis, Hepatic Encephalopathy
Trial Timeline
Dec 1, 2009 → Apr 1, 2012
NCT ID
NCT00999167About HPN-100 + Placebo
HPN-100 + Placebo is a phase 2 stage product being developed by Amgen for Cirrhosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00999167. Target conditions include Cirrhosis, Hepatic Encephalopathy.
What happened to similar drugs?
6 of 11 similar drugs in Cirrhosis were approved
Approved (6) Terminated (0) Active (5)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00999167 | Phase 2 | Completed |
Competing Products
20 competing products in Cirrhosis